Have a personal or library account? Click to login
Thrombophilia genetic testing in Romanian young women with acute thrombotic events: role of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and A1298C polymorphisms / Evaluarea genetică a trombofiliilor la femei tinere din România cu evenimente acute trombotice: rolul Factorului V Leiden, Protrombinei G20210A, polimorfismelor MTHFR C677T și A1298C Cover

Thrombophilia genetic testing in Romanian young women with acute thrombotic events: role of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and A1298C polymorphisms / Evaluarea genetică a trombofiliilor la femei tinere din România cu evenimente acute trombotice: rolul Factorului V Leiden, Protrombinei G20210A, polimorfismelor MTHFR C677T și A1298C

Open Access
|Oct 2016

References

  1. 1. Spencer FA, Kroll A, Lessard D, Emery C, Glushchenko AV, Pacifico L, et al. Isolated calf deep vein thrombosis in the community setting: the Worcester Venous Thromboembolism study. J. Thromb. Thrombolysis. 2012;33(3):211-7. DOI: 10.1007/s11239-011-0670-x.10.1007/s11239-011-0670-x22261699
  2. 2. Ng KW, Loh PK, Sharma VK. Role of investigating thrombophilic disorders in young stroke. Stroke research and treatment. 2011;2011.10.4061/2011/670138303879621331344
  3. 3. Yokus O, Albayrak M, Balcik OS, Ceran F, Dagdas S, Yilmaz M, et al. Risk factors for thrombophilia in young adults presenting with thrombosis. Int. J. Hematol. 2009;90(5):583-90. DOI: 10.1007/s12185-009-0447-6.10.1007/s12185-009-0447-619937485
  4. 4. Jadaon MM. Epidemiology of activated protein C resistance and Factor V Leiden mutation in the Mediterranean Region. Mediterr. J. Hematol. Infect. Dis. 2011;3:e2011037. DOI: 10.4084/mjhid.2011.037 DOI: 10.4084/mjhid.2011.054.10.4084/mjhid.2011.037
  5. 5. Jadaon MM. Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region. Mediterr.
  6. J. Hematol. Infect. Dis. 2011;3(1):e2011054. DOI: 10.4084/mjhid.2011.037 DOI: 10.4084/mjhid.2011.054.10.4084/mjhid.2011.037
  7. 6. Prandoni P. Links between arterial and venous disease. J. Intern. Med. 2007;262(3):341-50. DOI: 10.1111/j.1365-2796.2007.01815.x.10.1111/j.1365-2796.2007.01815.x17697155
  8. 7. Prandoni P. Venous and arterial thrombosis: Two aspects of the same disease? Clin. Epidemiol. 2009;1:1. DOI: 10.1016/j.ejim.2009.02.001 DOI: 10.2147/clep. s4780.10.1016/j.ejim.2009.02.00119782933
  9. 8. Collaboration HS. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288(16):2015-22. DOI: 10.1001/ jama.288.16.2015.10.1001/jama.288.16.201512387654
  10. 9. Eldibany MM, Caprini JA. Hyperhomocysteinemia and thrombosis: an overview. Arch. Pathol. Lab. Med. 2007;131(6):872-84.
  11. 10. Trenor CC, Chung RJ, Michelson AD, Neufeld EJ, Gordon CM, Laufer MR, et al. Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics. 2011;127(2):347-57. DOI: 10.1542/ peds.2010-2221.10.1542/peds.2010-2221302541721199853
  12. 11. Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, et al. Clinical guidelines for testing for heritable thrombophilia. Br. J. Haematol. 2010;149(2):209-20. DOI: 10.1111/j.1365-2141.2009.08022.x.10.1111/j.1365-2141.2009.08022.x20128794
  13. 12. Wu O, Robertson L, Twaddle S, Lowe G, Clark P, Greaves M, et al. Screening for thrombophilia in highrisk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. 2006.10.3310/hta1011016595080
  14. 13. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369(6475):64-7. DOI: 10.1038/369064a0.10.1038/369064a08164741
  15. 14. Ferraresi P, Marchetti G, Legnani C, Cavallari E, Castoldi E, Mascoli F, et al. The heterozygous 20210G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler. Thromb. Vasc. Biol. 1997;17(11):2418-22. DOI: 10.1161/01.ATV.17.11.2418.10.1161/01.ATV.17.11.2418
  16. 15. A ZC, Yang Y, Zhang SZ, Li N, Zhang W. Single nucleotide polymorphism C677T in the methylenetetrahydrofolate reductase gene might be a genetic risk factor for infertility for Chinese men with azoospermia or severe oligozoospermia. Asian J Androl. 2007;9(1):57-62. DOI: 10.1111/j.1745-7262.2007.00225.x.10.1111/j.1745-7262.2007.00225.x16888682
  17. 16. Wu J, Li Y-z, Ma H-y, Bai J, Chen F, Fu S-b. Association between single nucleotide polymorphisms of MTHFR gene and susceptibility of psoriasis. Int J Genet. 2007;30(3):173-7.
  18. 17. Shaheen K, Alraies MC, Alraiyes AH, Christie R. Factor V Leiden: How great is the risk of venous thromboembolism? Cleve. Clin. J. Med. 2012;79(4):265-72. DOI: 10.3949/ccjm.79a.11072.10.3949/ccjm.79a.1107222473726
  19. 18. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular Disease in Women A Statement for Healthcare Professionals From the American Heart Association.Circulation. 1997;96(7):2468-82. DOI: 10.1161/01. CIR.96.7.2468
  20. 10. Trenor CC, Chung RJ, Michelson AD, Neufeld EJ, Gordon CM, Laufer MR, et al. Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics. 2011;127(2):347-57. DOI: 10.1542/ peds.2010-2221.10.1542/peds.2010-2221302541721199853
  21. 11. Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, et al. Clinical guidelines for testing for heritable thrombophilia. Br. J. Haematol. 2010;149(2):209-20. DOI: 10.1111/j.1365-2141.2009.08022.x.10.1111/j.1365-2141.2009.08022.x20128794
  22. 12. Wu O, Robertson L, Twaddle S, Lowe G, Clark P, Greaves M, et al. Screening for thrombophilia in highrisk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. 2006.10.3310/hta10110
  23. 13. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369(6475):64-7. DOI: 10.1038/369064a0.10.1038/369064a0
  24. 14. Ferraresi P, Marchetti G, Legnani C, Cavallari E, Castoldi E, Mascoli F, et al. The heterozygous 20210G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler.Thromb. Vasc. Biol. 1997;17(11):2418-22. DOI: 10.1161/01.ATV.17.11.2418.10.1161/01.ATV.17.11.2418
  25. 15. A ZC, Yang Y, Zhang SZ, Li N, Zhang W. Single nucleotide polymorphism C677T in the methylenetetrahydrofolate reductase gene might be a genetic risk factor for infertility for Chinese men with azoospermia or severe oligozoospermia. Asian J Androl. 2007;9(1):57-62. DOI: 10.1111/j.1745-7262.2007.00225.x.10.1111/j.1745-7262.2007.00225.x16888682
  26. 16. Wu J, Li Y-z, Ma H-y, Bai J, Chen F, Fu S-b. Association between single nucleotide polymorphisms of MTHFR gene and susceptibility of psoriasis. Int J Genet. 2007;30(3):173-7.
  27. 17. Shaheen K, Alraies MC, Alraiyes AH, Christie R. Factor V Leiden: How great is the risk of venous thromboembolism? Cleve. Clin. J. Med. 2012;79(4):265-72.DOI: 10.3949/ccjm.79a.11072.10.3949/ccjm.79a.1107222473726
  28. 18. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular Disease in Women A Statement for Healthcare Professionals From the American Heart Association. Circulation. 1997;96(7):2468-82. DOI: 10.1161/01. CIR.96.7.2468.
  29. 19. Lowe G. Common risk factors for both arterial and venous thrombosis. Br. J. Haematol. 2008;140(5):488-95. DOI: 10.1111/j.1365-2141.2007.06973.x.10.1111/j.1365-2141.2007.06973.x18275426
  30. 20. Zoller B, de Frutos PG, Hillarp A, Dahlback B. Thrombophilia as a multigenic disease. Haematologica. 1999;84(1):59-70.
  31. 21. Chan MY, Andreotti F, Becker RC. Hypercoagulable states in cardiovascular disease. Circulation. 2008;118(22):2286-97. DOI: 10.1161/CIRCULATIONAHA.108.778837.10.1161/CIRCULATIONAHA.108.77883719029477
  32. 22. Otten AM, Maas AH, Ottervanger JP, Kloosterman A, van’t Hof AW, Dambrink JHE, et al. Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age. European Heart Journal: Acute Cardiovascular Care. 2013;2(4):334-41. DOI: 10.1177/2048872612475270.10.1177/2048872612475270382182524338292
  33. 23. Yang X-P, Reckelhoff JF. Estrogen, hormonal replacement therapy and cardiovascular disease. Curr. Opin. Nephrol. Hypertens. 2011;20(2):133. DOI: 10.1097/ MNH.0b013e3283431921.10.1097/MNH.0b013e3283431921312388421178615
  34. 24. Maas A, Appelman Y. Gender differences in coronary heart disease. Neth. Heart J. 2010;18(12):598-603. DOI: 10.1007/s12471-010-0841-y.10.1007/s12471-010-0841-y301860521301622
  35. 25. Hanson NQ, Aras O, Yang F, Tsai MY. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin. Chem. 2001;47(4):661-6.
  36. 26. de Bree A, Verschuren WM, Bjorke-Monsen AL, van der Put NM, Heil SG, Trijbels FJ, et al. Effect of the methylenetetrahydrofolate reductase 677C-- >T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am. J. Clin. Nutr. 2003;77(3):687-93.
  37. 27. Rosendorff A, Dorfman DM. Activated protein C resistance and factor V Leiden. Arch. Pathol. Lab. Med. 2007;131(6):866-71.
  38. 28. Djordjevic V, Rakicevic L, Mikovic D, Kovac M, Miljic P, Radojkovic D, et al. Prevalence of factor V leiden, factor V cambridge, factor II G20210A and methylenetetrahydrofolate reductase C677T mutations in healthy and thrombophilic Serbian populations. Acta Haematol. 2004;112(4):227-9. DOI: 10.1159/000081280. 10.1159/00008128015564739
  39. 29. Jukić I, Bingulac-Popović J, Đogić V, Babić I, Culej J, Tomičić M, et al. ABO blood groups and genetic risk factors for thrombosis in Croatian population. Croat. Med. J. 2009;50(6):550-8. DOI: 10.3325/ cmj.2009.50.550.10.3325/cmj.2009.50.550280208820017223
  40. 30. Stankovics J, Melegh B, Nagy A, Kis A, Molnar J, Losonczy H, et al. [Incidence of factor V G1681A (Leiden) mutation in samplings from the Hungarian population]. Orv. Hetil. 1998;139(19):1161-3.
  41. 31. Cushman M, Rosendaal FR, Psaty BM, Cook EF, Valliere J, Kuller LH, et al. Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study. Thromb. Haemost. 1998;79(5):912-5.
  42. 32. Rosendaal F, Siscovick D, Schwartz S, Beverly R, Psaty B, Longstreth Jr W, et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood. 1997;89(8):2817-21.10.1182/blood.V89.8.2817
  43. 33. Hotoleanu C, Popp R, Trifa A. Factor V Leiden, prothrombin G20210A and MTHFR C677T mutations in Romanian patients with deep venous thrombosis. HVM Bioflux. 2014;6(1):15-9.
  44. 34. Alfirevic Z, Simundic A-M, Nikolac N, Sobocan N, Alfirevic I, Stefanovic M, et al. Frequency of factor II G20210A, factor V Leiden, MTHFR C677T and PAI-1 5G/4G polymorphism in patients with venous thromboembolism: Croatian case-control study. Biochemia Medica. 2010;20(2):229-35. DOI: 10.11613/ BM.2010.028.10.11613/BM.2010.028
  45. 35. Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation. 1999;99(8):999-1004. DOI: 10.1161/01.CIR.99.8.99910.1161/01.CIR.99.8.999
  46. 36. Hotoleanu C, Trifa A, Popp R, Fodor D. The Importance of homozygous polymorphisms of methylenetetrahydrofolate reductase gene in romanian patients with idiopathic venous thromboembolism. Balkan medical journal. 2013;30(2):197. DOI: 10.5152/balkanmedj. 2013.7159.10.5152/balkanmedj
  47. 37. Shmeleva VM, Kapustin SI, Papayan LP, Sobczyńska- Malefora A, Harrington DJ, Savidge GF. Prevalence of hyperhomocysteinemia and the MTHFR C677T polymorphism in patients with arterial and venous thrombosis from North Western Russia. Thromb. Res. 2003;111(6):351-6. DOI: 10.1016/j.thromres. 2003.10.004.
  48. 38. Nizankowska-Mogilnicka E, Adamek L, Grzanka P, Domagala T, Sanak M, Krzanowski M, et al. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis. Eur. Respir. J. 2003;21(1):25-30. DOI: 10.1183/09031936.03.00034302.10.1183/09031936.03.0003430212570104
  49. 39. Bezemer ID, Doggen CJ, Vos HL, Rosendaal FR. No association between the common MTHFR 677C→ T polymorphism and venous thrombosis: results from the MEGA study. Arch. Intern. Med. 2007;167(5):497-501.DOI: 10.1001/archinte.167.5.497.10.1001/archinte.167.5.49717353498
  50. 40. De Stefano V, Zappacosta B, Persichilli S, Rossi E, Casorelli I, Paciaroni K, et al. Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease. Br. J. Haematol. 1999;106(2):564-8. DOI: 10.1046/j.1365-2141.1999.01613.x. 10.1046/j.1365-2141.1999.01613.x10460623
DOI: https://doi.org/10.1515/rrlm-2016-0032 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 291 - 305
Submitted on: Jun 13, 2016
Accepted on: Sep 5, 2016
Published on: Oct 15, 2016
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 Ana Maria Daraban, Adrian Pavel Trifa, Radu Anghel Popp, Diana Botezatu, Marinela Șerban, Valentina Uscatescu, Rodica Talmaci, Daniel Coriu, Carmen Ginghina, Ruxandra Oana Jurcut, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.